Abstract:Precise genome-editing platforms are versatile tools for generating specific, site-directed DNA insertions, deletions, and substitutions. The continuous enhancement of these tools has led to a revolution in the life sciences, which promises to deliver novel therapies for genetic disease. Precise genome-editing can be traced back to the 1950s with the discovery of DNA's double-helix and, after 70 years of development, has evolved from crude in vitro applications to a wide range of sophisticated capabilities, including in vivo applications. Nonetheless, precise genome-editing faces constraints such as modest efficiency, delivery challenges, and off-target effects. In this review, we explore precise genome-editing, with a focus on introduction of the landmark events in its history, various platforms, delivery systems, and applications. First, we discuss the landmark events in the history of precise genome-editing. Second, we describe the current state of precise genome-editing strategies and explain how these techniques offer unprecedented precision and versatility for modifying the human genome. Third, we introduce the current delivery systems used to deploy precise genome-editing components through DNA, RNA, and RNPs. Finally, we summarize the current applications of precise genome-editing in labeling endogenous genes, screening genetic variants, molecular recording, generating disease models, and gene therapy, including ex vivo therapy and in vivo therapy, and discuss potential future advances.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the challenge of achieving precise gene editing in human diseases. Specifically, the paper focuses on the following aspects: 1. **Historical Development**: It reviews the development process from the discovery of the DNA double - helix structure in the 1950s to modern precise gene - editing technologies, including the development of technologies such as homologous recombination (HR), Cre/LoxP system, zinc - finger nucleases (ZFNs), transcription activator - like effector nucleases (TALENs), CRISPR/Cas system and its derived base editors (BEs) and prime editors (PEs). 2. **Technical Strategies**: It elaborates on various current strategies and technologies for precise gene editing, including how to achieve highly precise and multi - functional modifications of the human genome through these technologies. It focuses on discussing the advantages and limitations of each technology, such as ZFNs, TALENs, CRISPR/Cas9, etc. 3. **Delivery Systems**: It explores the systems currently used for the delivery of precise gene - editing components, including the delivery methods of DNA, RNA and ribonucleoprotein complexes (RNPs). 4. **Application Areas**: It summarizes the applications of precise gene editing in marking endogenous genes, screening genetic variations, molecular recording, generating disease models and gene therapy (including in vitro and in vivo therapies), and discusses possible future development directions. The core objective of the paper is to provide a comprehensive overview to help readers understand the mechanisms, strategies and applications of precise gene editing in human diseases, as well as the challenges faced and future development prospects.

Precise genome-editing in human diseases: mechanisms, strategies and applications